Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 24, 2014Human Vaccines & ImmunotherapeuticsOpen Access

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRoman PrymulaCharles UniversitySESusanna EspositoUniversity of Parma
Gianvincenzo Zuccotti
Gianvincenzo ZuccottiOspedale dei Bambini Vittore Buzzi

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Prymula et al. (2014) studied this question.

synapsesocial.com/papers/6a730ebd0df8cba8e260e324https://doi.org/10.4161/hv.28666
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age2010 · 126 citations
  2. 2The Effect of Prophylactic Acetaminophen Administration on Reactions to DTP Vaccination1988 · 70 citations
  3. 3A Randomized Placebo-Controlled Trial of Acetaminophen for Prevention of Post-Vaccination Fever in Infants2011 · 26 citations
  4. 4Fever Phobia Revisited: Have Parental Misconceptions About Fever Changed in 20 Years?2001 · 468 citations